A triarylamine heterocyclic organic compound and its organic electroluminescent device

By combining triarylamine heterocyclic organic compounds with conventional host materials, the problem of poor carrier mobility matching in OLED devices was solved, carrier transport was optimized, luminous efficiency and stability were improved, and device lifespan was extended.

CN123106568APending Publication Date: 2026-11-17CHANGCHUN HYPERIONS TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611442056.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-16
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In existing OLED devices, the energy level structure and carrier mobility of the two host materials are poorly matched, resulting in unbalanced carrier transport, which easily leads to charge accumulation and exciton quenching, reducing luminous efficiency and lifetime.

Method used

A high-performance dual-host luminescent system is constructed by combining triarylamine heterocyclic organic compounds with conventional host materials, optimizing carrier transport characteristics and energy transfer. It is suitable for hole transport layers and device capping layers, balancing carrier transport.

Benefits of technology

This improved the device's luminous efficiency and color stability, extended its lifespan, reduced driving losses, and enhanced the device's overall performance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_30
    Figure SMS_30
Patent Text Reader

Abstract

This invention discloses a triarylamine heterocyclic organic compound and its organic electroluminescent device, belonging to the field of organic electroluminescent materials technology. Addressing the problems of poor energy level structure-carrier mobility matching and hole-electron transport rate imbalance in existing OLED emissive layer dual-host co-doped systems, which lead to charge accumulation, exciton quenching, reduced energy transfer efficiency, and accelerated device aging, this invention provides a triarylamine heterocyclic organic compound with strong structural stability, high energy level matching, and balanced carrier transport. This compound can be used as a P-type host in the emissive layer to construct a P+N dual-host system, balancing carrier transport and optimizing energy transfer; it can also be used as a hole transport layer to achieve balanced carrier transport and reduce driving losses; and it can also be used as a device capping layer to improve optical performance and protection capabilities. This invention can optimize the photoelectric performance and stability of OLED devices in multiple dimensions, suppress photoelectric losses, delay aging, improve luminous efficiency, color stability, and operating life, meeting the needs of high-performance, long-life OLED display and lighting devices.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of organic optoelectronic materials technology, specifically to a triarylamine heterocyclic organic compound and its organic electroluminescent device. Background Technology

[0002] Organic light-emitting diodes (OLEDs) are self-emissive light-emitting devices. They boast significant overall performance advantages due to their thin and flexible structure, low power consumption, high response speed, and excellent color rendering and environmental adaptability. With continuous innovation in light-emitting materials and device fabrication technologies, the OLED industry is maturing and, thanks to its unique technological advantages, will have broad market development prospects and commercialization potential in the optoelectronic display field.

[0003] OLEDs achieve electroluminescence using organic semiconductor materials. Under an applied electric field, electrons and holes injected into the electrodes migrate and recombine within the organic functional layers, efficiently converting electrical energy into visible light. The OLED device structure mainly consists of an anode, a cathode, and organic functional layers sandwiched between and outside the electrodes. The organic functional layer between the electrodes primarily includes a hole transport layer (HTL), an emissive layer (EML), and an electron transport layer (ETL). The capping layer (CP) on the outside of the electrodes is a key auxiliary functional layer, optimizing the device's optical performance, enhancing its protective capabilities, and effectively ensuring overall device stability. These functional layers work together synergistically to complete the entire process of carrier transport and photoelectric conversion. The emissive layer (EML) is the core functional unit that directly determines the device's luminescence performance and lifespan. Current emissive layers generally employ a dual-substrate co-doping system to optimize carrier transport performance; however, this system has a core technological weakness, primarily focusing on the poor matching between the energy level structure and carrier mobility between the two substrate materials. Insufficient compatibility between the two host materials can lead to an imbalance in the hole and electron transport rates within the device, easily causing loss phenomena such as charge accumulation and exciton quenching. This significantly reduces the energy transfer efficiency, resulting in decreased luminous efficiency, accelerated aging, and ultimately severely limiting the luminous performance and long-term service life of organic electroluminescent devices. Therefore, it is urgent to develop novel dual-host systems with high energy level matching and balanced carrier transport to fundamentally solve the carrier mismatch problem, suppress photoelectric losses, and improve the luminous stability and lifespan of the device. Summary of the Invention

[0004] To address the problems existing in the prior art, the present invention provides a triarylamine heterocyclic organic compound and its organic electroluminescent device, wherein the heterocyclic compound is shown in Formula 1.

[0005] X1 is selected from O atoms, S atoms, or NR0; The v may be the same or different from CR1, C atom or N atom, and the v at the bonding site is selected from C atom; The ring A is selected from substituted or unsubstituted C6-C30 aromatic rings or substituted or unsubstituted C6-C30 heteroaromatic rings; The Ar1 is selected from the group shown in Formula II:

[0006] The X and Y are selected from O atoms, S atoms, CR2R3 or NR4, whether they are the same or different. The rings B1, B2, and B3 are selected from substituted or unsubstituted aromatic rings of C6 to C30 or heteroaromatic rings of C6 to C30, and at least one of the rings is connected to L1. The R, R1, R2, and R3 are selected from any one of the following, either identically or differently: hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C1-C20 heterocycloalkyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring, or two adjacent R1s are connected to each other to form a substituted or unsubstituted ring. R0 and R4 are selected from any one of the following, whether identical or different: hydrogen, deuterium, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring; The Ar is selected from any one of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C1-C20 heterocycloalkyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C6-C30 heteroaryl, substituted or unsubstituted fused cycloyl group of alicyclic and aromatic ring of C3-C20 and C6-C30, and substituted or unsubstituted fused cycloyl group of alicyclic and aromatic ring of C6-C30. L1, L2, and L3 are selected from one of the following: single bond, substituted or unsubstituted C6-C30 arylene, substituted or unsubstituted C2-C30 heteroarylene, substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic rings in a fused cycloalcoholic group, or substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroarylene rings in a fused cycloalcoholic group.

[0007] The present invention also provides an organic electroluminescent device comprising an anode, a cathode, and an organic layer, wherein the organic layer is located between the anode and the cathode or outside at least one of the electrodes of the anode and the cathode, and the organic layer comprises at least one of the heterocyclic compounds described in the present invention.

[0008] Beneficial Effects: This invention provides a triarylamine heterocyclic organic compound that can be compounded with conventional host materials to construct a high-performance dual-host luminescent system. This effectively solves the core problem of energy level and carrier mobility mismatch in traditional materials, optimizes carrier transport characteristics and energy transfer efficiency, reduces charge loss, and improves device luminous efficiency and color stability. This compound has broad compatibility and strong structural stability, and can also be applied to hole transport layers and device capping layers. It can balance carrier transport, reduce driving losses, delay device aging, and improve the overall performance and lifespan of the device in multiple dimensions. Detailed Implementation

[0009] The present invention will be further illustrated below with reference to specific embodiments. It should be understood that these embodiments are for illustrative purposes only and are not intended to limit the scope of the invention. After reading the present invention, any modifications of the present invention in various equivalent forms by those skilled in the art will fall within the scope defined by the appended claims.

[0010] In the compounds of this invention, any atom not specified as a particular isotope includes any stable isotope of that atom, and includes atoms at both their natural and non-natural isotopic abundances.

[0011] The halogens mentioned in this invention refer to fluorine, chlorine, bromine, and iodine.

[0012] The alkyl group described in this invention refers to a monovalent group in an alkane molecule after removing one hydrogen atom. It can be a straight-chain alkyl group or a branched-chain alkyl group, preferably having 1 to 12 carbon atoms, more preferably having 1 to 8 carbon atoms, and particularly preferably having 1 to 6 carbon atoms. Examples may include methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, isobutyl, sec-butyl, n-pentyl, isopentyl, n-hexyl, etc., but are not limited thereto.

[0013] The cycloalkyl group described in this invention refers to a hydrocarbon group formed by removing one hydrogen atom from a cycloalkane molecule, preferably having 3 to 15 carbon atoms, more preferably 3 to 12 carbon atoms, and particularly preferably 5 to 10 carbon atoms. Examples may include cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, adamantane, norbornene, etc., but are not limited thereto. The aforementioned cycloalkyl groups are preferably cyclopentane, cyclohexane, 1-adamantane, or 2-adamantane.

[0014] The heterocyclic alkyl group described in this invention refers to a group formed by removing one hydrogen atom from a heterocyclic molecule in which the atoms constituting the ring contain at least one heteroatom in addition to carbon atoms. The heteroatom includes, but is not limited to, oxygen, sulfur, nitrogen, or phosphorus, and preferably has 1 to 25 carbon atoms, more preferably 1 to 15 carbon atoms, more preferably 2 to 12 carbon atoms, and particularly preferably 2 to 6 carbon atoms. Examples include piperidinyl, piperazineyl, morpholinyl, thiomorpholinyl, ethylene oxide, cyclothioethylene, tetrahydropyrrolyl, etc., but are not limited thereto.

[0015] The alkenyl group described in this invention refers to a monovalent group formed by removing one hydrogen atom from an olefin molecule, preferably having 2 to 12 carbon atoms, more preferably 2 to 6 carbon atoms. Examples may include vinyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, etc., but are not limited thereto.

[0016] The alkynyl group described in this invention refers to a monovalent group obtained by removing one hydrogen atom from an alkyne molecule. It can be a straight-chain alkynyl group or a branched-chain alkynyl group, preferably having 2 to 12 carbon atoms, more preferably 2 to 6 carbon atoms. The alkynyl group can be substituted or unsubstituted. Specific examples may include ethynyl, 1-propynyl, 2-propynyl, butynyl, pentyynyl, 3-methyl-1-butynyl, phenylethynyl, etc., but are not limited thereto.

[0017] The alkoxy group described in this invention refers to a monovalent group formed by removing one hydrogen atom from an alkoxy hydrocarbon molecule, preferably having 1 to 12 carbon atoms, more preferably 1 to 6 carbon atoms. Examples may include methoxy, ethoxy, propoxy, butoxy, etc., but are not limited thereto.

[0018] The aryloxy group described in this invention refers to a monovalent oxygen-containing group formed by the attachment of an aromatic ring to an oxygen atom. It is obtained by removing a hydrogen atom from a hydroxyl group and then combining it with an aromatic hydrocarbon group. The aromatic ring portion can be a monocyclic aryl, a fused-ring aryl, or a biaryl, and the aromatic ring may have substituents or no substituents. Preferably, the aryloxy group contains 6 to 30 carbon atoms, more preferably 6 to 20 carbon atoms, particularly preferably 6 to 15 carbon atoms, and most preferably 6 to 12 carbon atoms. Specific examples may include phenoxy, methylphenoxy, chlorophenoxy, naphthoxy, biphenoxy, fluorenoxy, etc., but are not limited thereto.

[0019] The aryl group described in this invention refers to the general term for a monovalent group remaining after removing a hydrogen atom from the aromatic carbon atom of an aromatic compound molecule. It can be a monocyclic aryl, polycyclic aryl, or fused-ring aryl, preferably having 6 to 30 carbon atoms, more preferably 6 to 20 carbon atoms, particularly preferably 6 to 14 carbon atoms, and most preferably 6 to 12 carbon atoms. The monocyclic aryl refers to an aryl group with only one aromatic ring in the molecule, such as phenyl, but not limited to this. The polycyclic aryl refers to an aryl group containing two or more independent aromatic rings in the molecule, such as biphenyl, terphenyl, tetraphenyl, 1-phenylnaphthyl, 2-phenylnaphthyl, etc., but not limited to this. The fused-ring aryl refers to an aryl group containing two or more aromatic rings fused together by sharing two adjacent carbon atoms, such as naphthyl, anthracene, phenanthrene, triphenylene, pyrene, perylene, fluoranyl, fluorene, benzo[a]fluorene, spirofluorene, spirodifluorene, etc., but not limited to this.

[0020] The heteroaryl group described in this invention refers to the general term for groups obtained by replacing one or more aromatic carbon atoms in an aryl group with heteroatoms. The heteroatoms include, but are not limited to, oxygen, sulfur, nitrogen, silicon, selenium, or phosphorus atoms, preferably having 2 to 30 carbon atoms, more preferably 2 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, and most preferably 3 to 12 carbon atoms. The linking site of the heteroaryl group can be located on a cyclic carbon atom or on a cyclic nitrogen atom. The heteroaryl group can be a monocyclic heteroaryl, a polycyclic heteroaryl, or a fused-ring heteroaryl. Specific examples of the monocyclic heteroaryl group may include pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, pyrrolithyl, furanyl, thiopheneyl, oxazolyl, thiazolyl, imidazolyl, etc., but are not limited thereto; specific examples of the polycyclic heteroaryl group may include bipyridyl, bipyrimidinyl, phenylpyridinyl, phenylpyrimidinyl, etc., but are not limited thereto; specific examples of the fused-ring heteroaryl group may include spirofluorenoxanthyl, spirofluorenthixanthyl, acridinel, 9,10-dihydroacridinyl, naphridinyl, indolyl, phenoxazinyl Phenothiazinyl, phenoxathialyl, quinolinyl, isoquinolinyl, benzoquinolinyl, benzoisoquinolinyl, quinazolinyl, benzoquinazolinyl, quinoxalinyl, benzoquinoxalinyl, o-phenanthrolinel, benzofuranyl, dibenzofuranyl, benzodibenzofuranyl, benzothiopheneyl, benzothiazolyl, dibenzothiopheneyl, benzodibenzothiopheneyl, benzooxazolyl, dibenzooxazolyl, benzoimidazolyl, dibenzoimidazolyl, dibenzothiazolyl, carbazoleyl, benzocarbazoleyl, etc., but not limited to these.

[0021] The fused alicyclic and aromatic cyclic group described in this invention refers to a monovalent group formed by removing one hydrogen atom after the alicyclic and aromatic rings are fused together. Preferably, it has 7 to 30 carbon atoms, more preferably 7 to 18 carbon atoms, and most preferably 7 to 13 carbon atoms, such as benzocyclopropyl, benzocyclobutyl, benzocyclopentyl, benzocyclohexyl, benzocycloheptyl, benzocyclopentenyl, benzocyclohexenyl, benzocycloheptenyl, naphthocyclopropyl, naphthocyclobutyl, naphthocyclopentyl, naphthocyclohexyl, etc., but is not limited thereto.

[0022] The fused cyclic groups of alicyclic and heteroaromatic rings mentioned in this invention refer to the general term for monovalent groups remaining after a hydrogen atom is removed from the fused alicyclic and heteroaromatic rings. Preferably, it has 5 to 30 carbon atoms, more preferably 5 to 18 carbon atoms, and most preferably 5 to 12 carbon atoms. Examples may include pyridocyclopropyl, pyridocyclobutyl, pyridocyclopentyl, pyridocyclohexyl, pyridinium benzocycloheptyl, pyrimidinium cyclopropyl, pyrimidinium cyclobutyl, pyrimidinium cyclopentyl, pyrimidinium benzocyclohexyl, dibenzofuranocyclopropyl, dibenzofuranocyclobutyl, dibenzofuranocyclopentyl, dibenzofuranocyclohexyl, dibenzofuranocycloheptyl, dibenzothiophenecyclopropyl, dibenzothiophenecyclobutyl, dibenzothiophenecyclopentyl, dibenzothiophenecyclohexyl, dibenzothiophenecycloheptyl, carbazocyclopropyl, carbazocyclobutyl, carbazocyclopentyl, carbazocyclohexyl, carbazocycloheptyl, etc., but are not limited thereto.

[0023] The arylene group described in this invention refers to an aryl group with two bonding sites, i.e., a divalent group. The above description of aryl groups can be applied to it, the difference being that the arylene group is a divalent group.

[0024] The term "hybrid aryl" in this invention refers to a heteroaryl group with two bonding sites, i.e., a divalent group. The above description of heteroaryl groups can be applied to it, the difference being that the hybrid aryl group is a divalent group.

[0025] The fused alicyclic and aromatic ring groups described in this invention refer to the divalent groups formed by removing two hydrogen atoms after the alicyclic and aromatic rings are fused together. The above description of fused alicyclic and aromatic ring groups can be applied to them, the difference being that the fused alicyclic and aromatic ring groups are divalent groups.

[0026] The fused alicyclic and heteroaromatic ring groups described in this invention refer to divalent groups formed by removing two hydrogen atoms after the alicyclic and heteroaromatic rings are fused together. Apart from being divalent groups, they are subject to the above description of fused alicyclic and heteroaromatic ring groups.

[0027] The term "substitution" as used in this invention refers to the replacement of a hydrogen atom in certain functional groups by another atom or functional group (i.e., a substituent), and the position of substitution is not limited, as long as the position is where the hydrogen atom is substituted. Furthermore, when two or more are substituted, the two or more substituents may be the same as or different from each other.

[0028] In this invention, "substituted or unsubstituted" means either unsubstituted or substituted by one or more substituents selected from the group consisting of: deuterium, tritium, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C60 aryl, substituted or unsubstituted C2-C60 heteroaryl, substituted or unsubstituted C1-C30 alkoxy, substituted or unsubstituted C1-C30 alkylboron, substituted or unsubstituted C6-C60 aryloxy, substituted or unsubstituted C6-C60 arylamine, substituted or unsubstituted C6-C60... The arylboryl group, substituted or unsubstituted silyl group, preferably a deuterium atom, tritium atom, halogen atom, cyano group, C1-C12 alkyl group, C3-C12 cycloalkyl group, C6-C30 aryl group, C2-C30 heteroaryl group, or silyl group, wherein when substituted by multiple substituents, the multiple substituents are the same or different from each other; preferably, it means unsubstituted or substituted by one or more substituents selected from the group consisting of: deuterium atom, tritium atom, fluorine atom, chlorine atom, bromine atom, iodine atom, cyano group, methyl group, trifluoromethyl group, deuterated methyl group, ethyl group, deuterated ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, deuterated tert-butyl group, etc. Butyl, cyclopropane, methyl-substituted cyclopropane, ethyl-substituted cyclopropane, deuterated cyclopropane, cyclobutane, methyl-substituted cyclobutane, ethyl-substituted cyclobutane, deuterated cyclobutane, cyclopentane, methyl-substituted cyclopentane, ethyl-substituted cyclopentane, deuterated cyclopentane, cyclohexane, methyl-substituted cyclohexane, ethyl-substituted cyclohexane, n-propyl-substituted cyclohexane, n-butyl-substituted cyclohexane, cyclohexane-substituted cyclohexane, deuterated cyclohexane, cycloheptane, adamantane, methyl-substituted adamantane, ethyl-substituted adamantane, deuterated adamantane, norbornyl, methyl-substituted norbornyl Ethyl-substituted norbornel, deuterated norbornel, tetrahydropyrrolyl, piperidinyl, phenyl, deuterated phenyl, naphthyl, deuterated naphthyl, anthracel, deuterated anthracel, phenanthryl, deuterated phenanthryl, triphenylene, pyrene, 9,9-dimethylfluorenyl, 9,9-diphenylfluorenyl, spirodifluorenyl, spiro-cyclopentyl-fluorenyl, spiro-cyclohexyl-fluorenyl, spiro-adamantyl-fluorenyl, pyridinyl, pyrimidinyl, triazinyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, N-phenylcarbazoyl, dibenzofuranyl, dibenzothiophenyl, trimethylsilyl, triphenylsilyl, when substituted with multiple substituents, the multiple substituents may be the same or different from each other.

[0029] In this invention, "adjacent groups connecting to form substituted or unsubstituted rings" refers to the formation of substituted or unsubstituted aromatic rings, heteroaromatic rings, aliphatic rings, or aliphatic heterocycles by the combination of adjacent groups and optional aromatization. The "adjacent groups" refer to two substituents on two directly connected atoms, a substituent positioned spatially closest to the corresponding substituent, or another substituent on an atom with a corresponding substituent. For example, two substituents substituted at the ortho position of a benzene ring or two substituents on the same carbon atom in an aliphatic ring can be considered "adjacent" to each other. The aliphatic ring and the aliphatic heterocycle can be saturated or unsaturated rings. Specifically, the rings formed can be three-membered, four-membered, five-membered, six-membered, seven-membered, spirocyclic, or fused rings. The aromatic ring formed preferably has 6 to 30 carbon atoms, particularly preferably 6 to 18 carbon atoms, and most preferably 6 to 12 carbon atoms. The heteroaromatic ring formed preferably has 2 to 30 carbon atoms, particularly preferably 2 to 18 carbon atoms, and most preferably 2 to 12 carbon atoms. The aliphatic ring formed preferably has 3 to 30 carbon atoms, particularly preferably 3 to 18 carbon atoms, more preferably 3 to 12 carbon atoms, and most preferably 3 to 7 carbon atoms. The aliphatic heterocycle formed preferably has 3 to 30 carbon atoms, particularly preferably 2 to 18 carbon atoms, more preferably 2 to 12 carbon atoms, and most preferably 2 to 7 carbon atoms. Furthermore, the rings formed by the connection can be, for example, benzene, naphthalene, indene, cyclopentane, cyclopentanophenene, cyclohexane, cyclohexanophenene, pyridine, quinoline, isoquinoline, benzofuran, benzothiophene, dibenzofuran, dibenzothiophene, phenanthrene, or pyrene, but are not limited to these.

[0030] In this invention, "at least one" includes one, two, three, or more. "Two or more" may include two, three, four, or more, where permissible.

[0031] In this specification, " "This refers to the portion that is connected to another substituent." "It can be attached to any optional position of the attached group / fragment."

[0032] In this specification, when a substituent or linking site lies within a bond that extends through two or more rings, it indicates that the substituent or linking site can be linked to any one of the two or more rings, specifically to any one of the corresponding optional sites within the ring. For example, It can be represented as or ; It can be represented as , , And so on.

[0033] In this specification, when the position of a substituent or linking site on the ring is not fixed, it means that it can be linked to any of the optional sites on the ring.

[0034] For example, Can represent , , ; can represent , , ; Can represent , , , , , , , , , And so on.

[0035] This invention provides a triarylamine heterocyclic organic compound, as shown in Formula 1.

[0036] X1 is selected from O atoms, S atoms, or NR0; The v may be the same or different from CR1, C atom or N atom, and the v at the bonding site is selected from C atom; The ring A is selected from substituted or unsubstituted C6-C30 aromatic rings or substituted or unsubstituted C6-C30 heteroaromatic rings; The Ar1 is selected from the group shown in Formula II:

[0037] The X and Y are selected from O atoms, S atoms, CR2R3 or NR4, whether they are the same or different. The rings B1, B2, and B3 are selected from substituted or unsubstituted aromatic rings of C6 to C30 or heteroaromatic rings of C6 to C30, and at least one of the rings is connected to L1. The R, R1, R2, and R3 are selected from any one of the following, either identically or differently: hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C1-C20 heterocycloalkyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring, or two adjacent R1s are connected to each other to form a substituted or unsubstituted ring. R0 and R4 are selected from any one of the following, whether identical or different: hydrogen, deuterium, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring; The Ar is selected from any one of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C1-C20 heterocycloalkyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C6-C30 heteroaryl, substituted or unsubstituted fused cycloyl group of alicyclic and aromatic ring of C3-C20 and C6-C30, and substituted or unsubstituted fused cycloyl group of alicyclic and aromatic ring of C6-C30. L1, L2, and L3 are selected from one of the following: single bond, substituted or unsubstituted C6-C30 arylene, substituted or unsubstituted C2-C30 heteroarylene, substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic rings in a fused cycloalcoholic group, or substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroarylene rings in a fused cycloalcoholic group.

[0038] Preferably, the " Choose from any of the following structures:

[0039] The limitation of v is the same as before.

[0040] More preferably, the " Choose from any of the following structures:

[0041] R and R1 are selected from hydrogen, deuterium, cyano, halogen, or substituted or unsubstituted groups of the following: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctyl, adamantyl, norbornel, cyclopentenyl, cyclohexenyl, cycloheptenyl, phenyl, biphenyl, terphenyl, naphthyl, anthracene, phenanthrene, phenylenetriene. The following are substituted or unsubstituted rings formed by the interconnection of two adjacent R1 groups: pyridyl, pyrimidinyl, pyrazinyl, triazinyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, naphthinyl, indolyl, furanyl, thiopheneyl, benzofuranyl, benzothiopheneyl, dibenzofuranyl, dibenzothiopheneyl, benzooxazolyl, benzimidazolyl, benzothiazolyl, carbazoleyl, dihydroindole, indole, tetrahydronaphthyl, and dihydronaphthyl. The R0 is selected from hydrogen, deuterium, and the following substituted or unsubstituted groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, adamantyl, norbornyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, phenyl, biphenyl, terphenyl, naphthyl, anthraceneyl. Any one of phenanthrene, triphenylene, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, naphthinyl, indolyl, furanyl, thiopheneyl, benzofuranyl, benzothiopheneyl, dibenzofuranyl, dibenzothiopheneyl, benzooxazolyl, benzimidazolyl, benzothiazolyl, carbazoleyl, dihydroindole, indole, tetrahydronaphthyl, and dihydronaphthyl; a2 is selected from 0, 1, or 2; a3 is selected from 0, 1, 2, or 3; a4 is selected from 0, 1, 2, 3, or 4; a5 is selected from 0, 1, 2, 3, 4, or 5; a6 is selected from 0, 1, 2, 3, 4, 5, or 6; a7 is selected from 0, 1, 2, 3, 4, 5, 6, or 7; a8 is selected from 0, 1, 2, 3, 4, 5, 6, 7, or 8; and a9 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9.

[0042] Preferably, Formula II is selected from any one of the following structures: .

[0043] Preferably, formula II is selected from any one of the following structures:

[0044] The Ra is selected from any one of the following, either identically or differently: hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring. b1 is selected from 0 or 1; b2 is selected from 0, 1 or 2; b3 is selected from 0, 1, 2 or 3; b4 is selected from 0, 1, 2, 3 or 4, either the same or different.

[0045] Preferably, the Ar is selected from any one or a combination of the following structures:

[0046] The u may be the same or different from CR5, C atom or N atom, and the u at the bonding site is selected from C atom; The ring E is selected from substituted or unsubstituted C3-C15 alicyclic rings; E1, E2, and E4 are selected from O atoms, S atoms, C (R6R7), or N (R8), either the same or different. The E3 is selected from CR9, C atoms, or N atoms; The R5, R6, R7, and R9 are selected from any one of the following, either identically or differently: hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring, or adjacent R5s are interconnected to form substituted or unsubstituted rings; The R8 is selected from any one of the following, either the same as or different from hydrogen, deuterium, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring.

[0047] More preferably, the Ar is selected from any one or a combination of the following structures:

[0048] R5 is selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted groups of the following: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctyl, adamantyl, norbornyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, phenyl, biphenyl, terphenyl, naphthyl, anthracene, phenanthrene, triphenylene, pyridyl, pyrimidinyl, pyrazinyl, triazine. The following are substituted or unsubstituted rings formed by the interconnection of adjacent R5 groups: alkyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, naphthidyl, indolyl, furanyl, thienyl, benzofuranyl, benzothienyl, dibenzofuranyl, dibenzothienyl, benzooxazolyl, benzimidazolyl, benzothiazolyl, carbazoleyl, silyl, dihydroindene, indene, tetrahydronaphthyl, dihydronaphthyl, benzocyclopropane, benzocyclobutane, benzocyclobutenyl, benzocycloheptane, and benzocycloheptenyl. The Rx is selected from any one of hydrogen, deuterium, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C2-C30 heteroaryl. The Ry groups are selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C2-C30 heteroaryl, either identical or different from each other; or adjacent Ry groups are linked to form any of the following ring structures:

[0049] The m2 is selected from 0, 1, or 2; the m3 is selected from 0, 1, 2, or 3; the m4 is selected from 0, 1, 2, 3, or 4; the m5 is selected from 0, 1, 2, 3, 4, or 5; the m6 is selected from 0, 1, 2, 3, 4, 5, or 6; the m7 is selected from 0, 1, 2, 3, 4, 5, 6, or 7; the m8 is selected from 0, 1, 2, 3, 4, 5, 6, 7, or 8; the m9 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9. The k2 is selected from 0, 1, or 2; the k4 is selected from 0, 1, 2, 3, or 4; the k6 is selected from 0, 1, 2, 3, 4, 5, or 6; the k7 is selected from 0, 1, 2, 3, 4, 5, 6, or 7; the k8 is selected from 0, 1, 2, 3, 4, 5, 6, 7, or 8; the k9 is selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9; the k 10 Selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; the k 11Selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11; the k 13 Selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, or 13; the k 14 Select from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14.

[0050] Preferably, L1, L2, and L3 are selected from single bonds, any one of the following structures, or a combination thereof, either identically or differently:

[0051] The i is selected from CR, whether the i is the same or different. 10 C or N atoms, with the i at the bonding site selected from C atoms; The M is selected from O atoms, S atoms, N(R) atoms, or different atoms. 11 ) or C(R 12 R 13 ); The ring J is selected from substituted or unsubstituted C3 to C15 alicyclic rings; The R 11 The same or different from any one of hydrogen, deuterium, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, and fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring; The R 12 R 13 It may be selected from the same or different groups of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring.

[0052] Preferably, L1, L2, and L3 are selected from single bonds, any one of the following structures, or a combination thereof, either identically or differently:

[0053] The R 10 The following groups, selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted, may be the same or different: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, adamantyl, norbornyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, phenyl, biphenyl, terphenyl, naphthyl, pyridyl, pyrimidinyl, pyrazinyl, triazinyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, naphthinyl, indolyl, furanyl, thienyl, benzofuranyl, benzothiophenyl, dibenzofuranyl, dibenzothiophenyl, benzoxazolyl, benzimidazolyl, benzothiazolyl, carbazole, and silyl. The Rb is selected from any one of the following, whether identical or different: hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted silyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, and fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring. The Ro is selected, either identically or differently, from any one of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, or substituted or unsubstituted C2-C30 heteroaryl; or adjacent two Ros are linked to form any one of the following ring structures:

[0054] The Rp is selected from any one of hydrogen, deuterium, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C2-C30 heteroaryl. The g1 is selected from 0 or 1; the g2 is selected from 0, 1 or 2; the g3 is selected from 0, 1, 2 or 3; the g4 is selected from 0, 1, 2, 3 or 4; the g5 is selected from 0, 1, 2, 3, 4 or 5; the g6 is selected from 0, 1, 2, 3, 4, 5 or 6; the g7 is selected from 0, 1, 2, 3, 4, 5, 6 or 7; the g8 is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8. h2 is selected from 0, 1, or 2; h4 is selected from 0, 1, 2, 3, or 4; h6 is selected from 0, 1, 2, 3, 4, 5, or 6; h8 is selected from 0, 1, 2, 3, 4, 5, 6, 7, or 8; h 10 Selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; h 14 Select from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14.

[0055] Preferably, the R 10 The substituents in "substituted or unsubstituted" are selected from one of the following groups that are substituted or unsubstituted by one or more deuterium groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl, cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctyl, adamantyl, norbornyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, phenyl, biphenyl, naphthyl, anthracene, phenanthrene, triphenylene, pyridine alkyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, naphthinyl, indolyl, furanyl, thiopheneyl, benzofuranyl, benzothiopheneyl, dibenzofuranyl, dibenzothiopheneyl, benzooxazolyl, benzimidazolyl, benzothiazolyl, carbazoleyl, silyl, dihydroindeneyl, indeneyl, tetrahydronaphthyl, dihydronaphthyl, benzocyclopropane, benzocyclobutane, benzocyclobutenyl, benzocycloheptaneyl, benzocycloheptenyl.

[0056] Most preferably, the triarylamine heterocyclic organic compound is selected from one of the following compounds: 。

[0057] In addition, the present invention also provides an organic electroluminescent device comprising an anode, a cathode and an organic layer, wherein the organic layer is located between the anode and the cathode or outside of at least one of the electrodes of the anode and the cathode, and the organic layer comprises at least one of the triarylamine heterocyclic organic compounds described in the present invention.

[0058] Preferably, the organic layer of the present invention is located between the anode and the cathode, and the organic layer comprises at least one of a hole transport region, a light-emitting layer, and an electron transport region, wherein at least one of the hole transport region and the light-emitting layer comprises at least one of the triarylamine heterocyclic organic compounds of the present invention.

[0059] Preferably, the organic layer of the present invention is located outside at least one of the electrodes, the anode and the cathode, and the organic layer includes a capping layer, the capping layer including at least one of the triarylamine heterocyclic organic compounds of the present invention.

[0060] The cathode described in this invention is preferably made of a material with a low work function, including metals, metal alloys, and conductive compounds. Specific examples include, but are not limited to, common low work function materials such as aluminum (Al), silver (Ag), magnesium (Mg), calcium (Ca), barium (Ba), beryllium (Be), magnesium-silver alloy (Mg:Ag), lithium-aluminum alloy (Li:Al), magnesium-beryllium alloy (Mg:Be), lithium-calcium alloy (Li:Ca), ytterbium (Yb), and dysprosium (Dy). These materials can effectively reduce the electron injection barrier and improve electron transport efficiency.

[0061] The hole injection layer described in this invention is preferably made of a material with high hole injection properties, such as triarylamine compounds, metal oxides, phthalocyanine derivatives, and conductive polymers. Specific examples include, but are not limited to, tetracyanoquinone dimethyl ether (TCNQ), molybdenum trioxide (MoO3), vanadium pentoxide (V2O5), copper phthalocyanine (CuPc), poly(3,4-ethylenedioxythiophene) / poly(styrene sulfonic acid) (PEDOT / PSS), and 1,4,5,8,9,11-hexaazabenzonitrile (HAT-CN).

[0062] The hole transport layer of this invention is preferably made of a material with high hole mobility, mainly selected from carbazole derivatives, aromatic amine derivatives, spirocyclic compounds, etc. Specific examples include, but are not limited to, N,N'-diphenyl-N,N'-(1-naphthyl)-1,1'-biphenyl-4,4'-diamine (NPB), 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (α-NPB), and N4,N4'-bis(biphenyl-4-yl)-N4,N4'-diphenylbiphenyl-4,4'-diamine (TP). Materials such as D-10), TPD, 4,4'-bis(9-carbazole)biphenyl (CBP), spiro-NPB, spiro-TPD, N,N'-di(4-methoxyphenyl)-N,N'-diphenylbiphenyl-4,4'-diamine (DMTPD), N,N'-di(3-methylphenyl)-N,N'-diphenyl-[1,1'-biphenyl]-4,4'-diamine (m-TPD), and the triaromatic amine heterocyclic organic compounds described in this invention, etc., can efficiently transport holes and reduce hole loss. The triaromatic amine heterocyclic organic compounds described in this invention are preferred.

[0063] The electron blocking layer described in this invention is preferably made of a material that combines high hole transport capability and electron blocking capability. Specific examples include, but are not limited to, N,N'-bis(3-methylphenyl)-N,N'-diphenyl-[1,1'-biphenyl]-4,4'-diamine (TPD), NPB, 4,4'-bis(9-carbazole)biphenyl (CBP), spiro-NPB, spiro-CBP, N,N'-diphenyl-N,N'-bis(4-(9-carbazole)phenyl)biphenyl-4,4'-diamine (CzTPD), and 2,2'-bis(4-carbazole)phenyl)biphenyl (mCBP). These materials effectively block electron diffusion to the hole transport layer, thereby improving luminescence efficiency.

[0064] The light-emitting layer described in this invention may contain only the guest material, or it may be in the form of the guest material being dispersed in the host material, wherein the host material may be composed of one or more materials.

[0065] The host material of the luminescent layer in this invention preferably uses a substance with a higher LUMO and a lower HOMO than the guest material. Examples include pyrene derivatives, styrylamine derivatives, fluoranthene derivatives, fluorene derivatives, diamine derivatives, triarylamine derivatives, and tetraphenyl derivatives. Specific examples include, but are not limited to, N,N'-bis[4-(9H-carbazole-9-yl)phenyl]-N,N'-diphenylstilbene-4,4'-diamine (abbreviated as YGA2S) and 4-(9H-carbazole-9-yl). 4'-(10-phenyl-9-anthrayl)triphenylamine (abbreviation: YGAPA), 4-(10-phenyl-9-anthrayl)-4'-(9-phenyl-9H-carbazole-3-yl)triphenylamine (abbreviation: PCPAPA), N-(9,10-diphenyl-2-anthrayl)-N,9-diphenyl-9H-carbazole-3-amine (abbreviation: 2PCPA), N-[9,10-bis(1,1'-biphenyl-2-yl)-2-anthrayl]-N,9-diphenyl-9H-carbazole-3-amine (abbreviation: 2PCPA) Abbreviations: 2PCABPhA), N-(9,10-diphenyl-2-anthrayl)-N,N',N'-triphenyl-1,4-phenylenediamine (abbreviation: 2DPAPA), N-[9,10-bis(1,1'-biphenyl-2-yl)-2-anthrayl]-N,N',N'-triphenyl-1,4-phenylenediamine (abbreviation: 2DPABPhA), N-[9,10-bis(1,1'-biphenyl-2-yl)]-N-[4-(9H-carbazole-9-yl)phenyl]-N-phenylanthracene 2-amine (abbreviated as: 2YGABPhA), N,N,9-triphenylanthracene-9-amine (abbreviated as: DPhAPhA), N,N,N',N'-tetra(4-methylphenyl)-tetraphenyl-5,11-diamine (abbreviated as: p-mPhTD), 7,14-diphenyl-N,N,N',N'-tetra(4-methylphenyl)acenaphthene[1,2-a]fluoranthene-3,10-diamine (abbreviated as: p-mPhAFD), and the triarylamine heterocyclic organic compounds described in this invention, but not limited thereto. Preferably, the triarylamine heterocyclic organic compounds described in this invention are preferred.

[0066] The guest material of the luminescent layer of the present invention may include aromatic amine derivatives, fused aromatic ring derivatives, heterocyclic derivatives, metal complexes, etc. Specific examples include, but are not limited to, 4,4'-bis(4-(9H-carbazole-9-yl)styryl)biphenyl (BSB4), 4,4'-bis[4-(diphenylamino)styryl]biphenyl (BDAVBi), 10,10'-bis(3,5-bis(trifluoromethyl)phenyl)-9,9'-bianthracene (Ban-(3,5)-CF3), 5,6,11,12-tetraphenylbenzotetraphenyl (Rubrene), and coumarin 545T (C-525T)tris(2-phenyl-3-methylpyridine)iridium (Ir(3m ppy)3), bis(2-(naphth-2-yl)pyridine)(acetylacetone)iridium(III))(Ir(npy)2acac), tri(2-phenylpyridine)iridium(III))(Ir(ppy)3), bis[2-(4',6'-difluorophenyl)pyridine-N,C2']iridium(III)pyridinecarboxylate (FIrpic), bis[2-(3',5'-bistrifluoromethylphenyl)pyridine-N,C2']iridium(III)pyridinecarboxylate (Ir(CF3ppy)2(pic)), bis[2-(4',6'-difluorophenyl)pyridine-N,C2']iridium(III)acetylacetone (FIracac), etc., but not limited to these.

[0067] The electron injection layer described in this invention is preferably made of a material with high electron injection properties, including metals, metal salts, and metal oxides. Specific examples include, but are not limited to, commonly used electron injection materials such as lithium (Li), lithium fluoride (LiF), cesium fluoride (CsF), potassium fluoride (KF), cesium carbonate (Cs2CO3), potassium carbonate (K2CO3), lithium oxide (Li2O), magnesium oxide (MgO), cesium oxide (Cs2O), metallic cesium (Cs), and metallic rubidium (Rb), which can reduce the electron injection barrier and improve the electron injection effect.

[0068] The electron transport layer of this invention is preferably made of a material with high electron mobility, mainly imidazole derivatives, phenanthroline derivatives, triazine derivatives, oxazole derivatives, oxadiazole derivatives, etc. Specific examples include, but are not limited to, 8-hydroxyquinoline aluminum (Alq3), 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), 4,4'-bis(4,6-diphenyl-1,3,5-triazin-2-yl)biphenyl (BTB), TPBi, BPhen, Bphen-F, DPVBi, OXD-7, PBD, but are not limited thereto.

[0069] The hole blocking layer of the present invention is preferably made of a material with good hole blocking capability and energy level matching. Metal complexes, heteroaromatic compounds, triazine derivatives, etc. can be selected. Specific examples include, but are not limited to, di(2-methyl-8-hydroxyquinoline-N1,O8)-(1,1'-biphenyl-4-hydroxy)aluminum (BAlq), TPBi, BCP, BPhen, OXD-7, PBD, BTB, but are not limited thereto.

[0070] The anode of this invention is preferably a material with a high work function, including metal oxides, metals and conductive polymers, composite electrodes, etc. Specific examples include, but are not limited to, indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO2), zinc oxide (ZnO), silver (Ag), gold (Au), platinum (Pt), ITO / Ag / ITO composite electrode, ITO / Al / ITO composite electrode, polyaniline (PANI), polythiophene (PTh) and other common anode materials. These materials can efficiently inject holes and ensure device stability.

[0071] The capping material of this invention is preferably a material with excellent light extraction performance, and can be selected from aromatic amine derivatives, metal complexes, inorganic oxides, small organic molecules, etc. Specific examples include, but are not limited to, Alq3, N,N'-di(naphthyl-1-yl)-N,N'-di(phenyl)-2,2'-dimethylbenzidine (NPD), CBP, magnesium fluoride (MgF2), calcium fluoride (CaF2), silicon dioxide (SiO2), silicon nitride (Si3N4), TPBi, BCP, and the triaromatic amine heterocyclic organic compound described in this invention, but is not limited to these. It can effectively improve the light extraction efficiency of the device and reduce light loss. The triaromatic amine heterocyclic organic compound described in this invention is preferred.

[0072] There are no particular limitations on the preparation method of each thin film in the organic electroluminescent device of the present invention. Vacuum evaporation, sputtering, spin coating, spraying, screen printing, laser transfer, etc. can be used, but are not limited to these methods.

[0073] The organic electroluminescent device of the present invention is mainly used in panel display, lighting, organic solar cells, organic thin film transistors, flexible OLEDs and other fields, but is not limited thereto.

[0074] The following embodiments illustrate the present invention in more detail; however, the embodiments described below are merely illustrative of this specification, and the scope of this specification is not limited to these embodiments.

[0075] The following is a method for preparing the triarylamine heterocyclic organic compound of Formula 1 of this invention, but the preparation method of this invention is not limited thereto. The core structure of the triarylamine heterocyclic organic compound of Formula 1 can be prepared by the reaction route shown below. The substituents can be bonded by methods known in the art, and the type and position or number of substituents can be changed according to techniques known in the art.

[0076] The triarylamine heterocyclic organic compound represented by Formula I of this invention can be prepared by the following synthetic route: Synthetic routes of the compounds:

[0077] Xm is a halogen, for example, Xm is selected from Cl, Br, I.

[0078] Raw materials and reagents: This invention does not impose any particular limitations on the raw materials or reagents used in the following synthesis examples. They can be commercially available products or prepared using methods well-known to those skilled in the art. All raw materials and reagents used in this invention are of reagent purity.

[0079] Instruments: G2-Si quadrupole tandem time-of-flight high-resolution mass spectrometer (Waters Corporation, UK); VarioELcube organic elemental analyzer (Elementar Corporation, Germany).

[0080] There are no particular limitations on the preparation method of the triarylamine heterocyclic organic compound of Formula 1 of this invention, and conventional methods well known to those skilled in the art can be used. For example, carbon-carbon coupling reaction, carbon-nitrogen coupling reaction, etc. The triarylamine heterocyclic organic compound of Formula 1 of this invention can be prepared by the synthetic route shown below.

[0081] Synthesis Example 1: Preparation of Intermediate c-23

[0082] Under nitrogen protection, starting material c'-23 (21.40 g, 80.00 mmol), starting material c''-23 (34.11 g, 80.00 mmol), K2CO3 (16.59 g, 120.00 mmol), and 400 mL of toluene / ethanol / water (2:1:1) mixed solvent were added to the reaction flask. After purging the air with nitrogen three times, Pd(PPh3)4 (0.92 g, 0.80 mmol) was added. The mixture was stirred and heated under reflux for 5 hours. After the reaction was completed, the mixture was cooled to room temperature, distilled water was added, and the toluene layer was separated and dried with anhydrous magnesium sulfate. After filtration, the solvent was concentrated by rotary evaporation, and crystals were precipitated by cooling. The crystals were then filtered and recrystallized from toluene to obtain intermediate c-23 (31.95 g, yield 82%) with an HPLC purity ≥99.85%. Mass spectrometry m / z: 486.1536 (theoretical value: 486.1547).

[0083] Synthesis Example 2: Preparation of Intermediate b-105

[0084] Preparation of intermediate B'-105: Under an argon atmosphere, starting material b'-105 (51.40 g, 120 mmol), starting material b''-105 (31.74 g, 125 mmol), and potassium acetate (15.7 g, 160 mmol) were added sequentially to a reaction flask. 600 mL of toluene was added, followed by PdCl2(dppf)Cl2 (0.88 g, 1.2 mmol). The mixture was stirred and refluxed for 10 h. The reaction solution was cooled to room temperature, filtered through diatomaceous earth to remove the catalyst, concentrated the filtrate, filtered under vacuum, and recrystallized from a dichloromethane-n-hexane mixed solvent to obtain intermediate B'-105 (48.49 g, yield 85%); HPLC purity ≥ 99.83%, mass spectrometry m / z: 475.1788 (theoretical value: 475.1777).

[0085] Preparation of intermediate b-105: Under nitrogen protection, starting material B'-105 (47.54 g, 100.00 mmol), starting material b'''-105 (19.71 g, 100.00 mmol), K2CO3 (20.73 g, 150.00 mmol), and 600 mL of toluene / ethanol / water (2:1:1) mixed solvent were added to a reaction flask. After purging the air with nitrogen three times, Pd(PPh3)4 (0.92 g, 0.80 mmol) was added. The mixture was stirred and the system was heated under reflux for 6 hours. After the reaction was completed, the mixture was cooled to room temperature, distilled water was added, and the toluene layer was separated and dried with anhydrous magnesium sulfate. After filtration, the solvent was concentrated by rotary evaporation, and the mixture was cooled to crystallize. After filtration, the mixture was recrystallized from toluene to obtain intermediate b-105 (42.84 g, yield 84%) with HPLC purity ≥99.86%. Mass spectrometry m / z: 509.1016 (theoretical value: 509.1005).

[0086] Synthesis Example 3: Preparation of Intermediate c-614

[0087] Following the same synthesis method as intermediate b-105 in Example 2, equimolar amounts of c'-614, b''-105, and c'''-614 were used to replace the original raw materials b'-105, b''-105, and b'''-105 to obtain intermediate c-614 (27.70 g); HPLC purity ≥ 99.87%, mass spectrometry m / z: 329.0618 (theoretical value: 329.0607).

[0088] Synthesis Example 4: Preparation of Compound 23

[0089] Preparation of intermediate A-23: Under nitrogen protection, a-23 (18.66 g, 80.00 mmol), b-23 (33.68 g, 80.00 mmol), Pd(OAc)2 (0.18 g, 0.80 mmol), 1.60 mL (0.80 mmol) of 0.5 mol / L P(t-Bu)3 toluene solution, NaO-tBu (11.53 g, 120.00 mmol) and 400 mL of toluene were added sequentially to the reaction flask. After stirring, the mixture was heated to reflux for 5 h. The system was cooled to room temperature, water was added, and dichloromethane was used for extraction. The organic phase was dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure, cooled to crystallize, and filtered. The crude product was recrystallized from toluene:ethanol = 10:1 to obtain intermediate A-23 (38.06 g, yield 77%). HPLC purity ≥ 99.84%, mass spectrometry m / z: 617.2731 (theoretical value: 617.2719).

[0090] Preparation of compound 23: Under nitrogen protection, intermediates A-23 (37.07 g, 60.00 mmol), c-23 (29.22 g, 60.00 mmol), Pd2(dba)3 (0.55 g, 0.60 mmol), BINAP (0.75 g, 1.20 mmol), NaO-tBu (11.53 g, 120.00 mmol), and 378 mL of toluene were added sequentially. The mixture was stirred and refluxed for 7 h. The reaction solution was cooled to room temperature, and water was added followed by extraction with dichloromethane. The organic phase was dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure, cooled to allow crystallization, filtered, and recrystallized from toluene to give compound 23 (47.43 g, yield 74%); HPLC purity ≥ 99.98%. Mass spectrometry m / z: 1067.4512 (theoretical value: 1067.4499). Molecular formula C 79 H 49 D5N2O2, theoretical elemental content (%): C, 88.82; H, 5.57; N, 2.62. Measured elemental content (%): C, 88.85; H, 5.59; N, 2.64.

[0091] Synthesis Example 5: Preparation of Compound 75

[0092] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-75, b-75, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 75 (45.96 g); HPLC purity ≥ 99.87%, mass spectrometry m / z: 1034.3631 (theoretical value: 1034.3621). Molecular formula C 79 H 49 D5N2O2, theoretical elemental content (%): C, 87.02; H, 4.48; N, 5.41. Measured elemental content (%): C, 87.03; H, 4.51; N, 5.43.

[0093] Synthesis Example 6: Preparation of Compound 105

[0094] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-105, b-105, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 105 (38.19 g); HPLC purity ≥ 99.94%, mass spectrometry m / z: 859.2671 (theoretical value: 859.2657). Molecular formula C 61 H 37N3OS, theoretical elemental content (%): C, 85.19; H, 4.34; N, 4.89. Measured elemental content (%): C, 87.02; H, 4.36; N, 4.92.

[0095] Synthesis Example 7: Preparation of Compound 222

[0096] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-222, b-222, and c-222 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 222 (33.07 g); HPLC purity ≥ 99.98%, mass spectrometry m / z: 744.2791 (theoretical value: 744.2777). Molecular formula C 54 H 36 N₂O₂, theoretical elemental content (%): C, 87.07; H, 4.87; N, 3.76. Measured elemental content (%): C, 87.09; H, 4.89; N, 3.78.

[0097] Synthesis Example 8: Preparation of Compound 227

[0098] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-227, b-222, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 227 (36.45 g); HPLC purity ≥ 99.98%, mass spectrometry m / z: 820.3099 (theoretical value: 820.3090). Molecular formula C 60 H 40 N₂O₂, theoretical elemental content (%): C, 87.78; H, 4.91; N, 3.41. Measured elemental content (%): C, 87.81; H, 4.93; N, 3.45.

[0099] Synthesis Example 9: Preparation of Compound 258

[0100] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-258, b-222, and c-258 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 258 (43.21 g); HPLC purity ≥ 99.95%, mass spectrometry m / z: 972.4281 (theoretical value: 972.4291). Molecular formula C 70 H 56N₂O₃, theoretical elemental content (%): C, 86.39; H, 5.80; N, 2.88. Measured elemental content (%): C, 86.41; H, 5.82; N, 2.89.

[0101] Synthesis Example 10: Preparation of Compound 264

[0102] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-264, b-264, and c-264 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 264 (34.23 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 770.2942 (theoretical value: 770.2933). Molecular formula C 56 H 38 N₂O₂, theoretical elemental content (%): C, 87.25; H, 4.97; N, 3.63. Measured elemental content (%): C, 87.27; H, 5.02; N, 3.66.

[0103] Synthesis Example 11: Preparation of Compound 293

[0104] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-293, b-222, and c-293 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 293 (34.45 g); HPLC purity ≥ 99.95%, mass spectrometry m / z: 775.3258 (theoretical value: 775.3247). Molecular formula C 56 H 33 D5N2O2, theoretical elemental content (%): C, 86.68; H, 5.58; N, 3.61. Measured elemental content (%): C, 86.69; H, 5.61; N, 3.63.

[0105] Synthesis Example 12: Preparation of Compound 308

[0106] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-308, b-308, and c-308 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 308 (30.85 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 694.2631 (theoretical value: 694.2620). Molecular formula C 50 H 34N₂O₂, theoretical elemental content (%): C, 86.43; H, 4.93; N, 4.03. Measured elemental content (%): C, 86.46; H, 4.94; N, 4.05.

[0107] Synthetic Example 13: Preparation of Compound 331

[0108] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-331, b-331, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 331 (36.58 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 823.2281 (theoretical value: 823.2293). Molecular formula C 57 H 33 N3O2S, theoretical elemental content (%): C, 83.09; H, 4.04; N, 5.10. Measured elemental content (%): C, 83.12; H, 4.07; N, 5.13.

[0109] Synthesis Example 14: Preparation of Compound 391

[0110] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-391, b-391, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 391 (38.63 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 869.3056 (theoretical value: 869.3042). Molecular formula C 63 H 39 N3O2, theoretical elemental content (%): C, 86.97; H, 4.52; N, 4.83. Measured elemental content (%): C, 86.98; H, 4.55; N, 4.85.

[0111] Synthesis Example 15: Preparation of Compound 392

[0112] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-105, b-392, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 392 (28.54 g); HPLC purity ≥ 99.94%, mass spectrometry m / z: 642.1957 (theoretical value: 642.1943). Molecular formula C 45 H 26N₂O₃, theoretical elemental content (%): C, 84.10; H, 4.08; N, 4.36. Measured elemental content (%): C, 84.12; H, 4.11; N, 4.39.

[0113] Synthetic Example 16: Preparation of Compound 395

[0114] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-391, b-395, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 395 (31.92 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 718.2267 (theoretical value: 718.2256). Molecular formula C 51 H 30 N₂O₃, theoretical elemental content (%): C, 85.22; H, 4.21; N, 3.90. Measured elemental content (%): C, 85.26; H, 4.23; N, 3.92.

[0115] Synthesis Example 17: Preparation of Compound 414

[0116] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-414, b-395, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 414 (35.29 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 794.2582 (theoretical value: 794.2569). Molecular formula C 57 H 34 N₂O₃, theoretical elemental content (%): C, 86.13; H, 4.31; N, 3.52. Measured elemental content (%): C, 86.14; H, 4.32; N, 3.55.

[0117] Synthesis Example 18: Preparation of Compound 422

[0118] Following the synthesis method of compound 23 in Example 4, equimolar amounts of a-422, b-395, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 422 (33.69 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 758.2582 (theoretical value: 758.2569). Molecular formula C 57 H 34N₂O₃, theoretical elemental content (%): C, 85.47; H, 4.52; N, 3.69. Measured elemental content (%): C, 85.49; H, 4.54; N, 3.70.

[0119] Synthesis Example 19: Preparation of Compound 423

[0120] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-423, b-395, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 423 (32.54 g); HPLC purity ≥ 99.95%, mass spectrometry m / z: 732.2061 (theoretical value: 732.2049). Molecular formula C 51 H 28 N₂O₄, theoretical elemental content (%): C, 83.59; H, 3.85; N, 3.82. Measured elemental content (%): C, 83.61; H, 3.87; N, 3.85.

[0121] Synthesis Example 20: Preparation of Compound 443

[0122] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-443, b-443, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 443 (32.14 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 723.2579 (theoretical value: 723.2570). Molecular formula C 51 H 25 D5N2O3, theoretical elemental content (%): C, 84.63; H, 4.87; N, 3.87. Measured elemental content (%): C, 84.66; H, 4.88; N, 3.89.

[0123] Synthesis Example 21: Preparation of Compound 454

[0124] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-454, b-454, and c-454 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 454 (32.98 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 742.2268 (theoretical value: 742.2256). Molecular formula C 53 H 30N₂O₃, theoretical elemental content (%): C, 85.70; H, 4.07; N, 3.77. Measured elemental content (%): C, 85.72; H, 4.10; N, 3.78.

[0125] Synthesis Example 22: Preparation of Compound 455

[0126] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-455, b-455, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 455 (35.12 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 790.2663 (theoretical value: 790.2652). Molecular formula C 54 H 38 N₂O₃Si, theoretical elemental content (%): C, 82.00; H, 4.84; N, 3.54. Measured elemental content (%): C, 82.03; H, 4.86; N, 3.55.

[0127] Synthesis Example 23: Preparation of Compound 503

[0128] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-503, b-503, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 503 (34.14 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 768.2430 (theoretical value: 768.2413). Molecular formula C 55 H 32 N₂O₃, theoretical elemental content (%): C, 85.92; H, 4.20; N, 3.64. Measured elemental content (%): C, 85.95; H, 4.21; N, 3.65.

[0129] Synthesis Example 24: Preparation of Compound 562

[0130] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-562, b-562, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 562 (29.47 g); HPLC purity ≥ 99.94%, mass spectrometry m / z: 663.2045 (theoretical value: 663.2029). Molecular formula C 45 H 21D5N2O2S, theoretical elemental content (%): C, 81.42; H, 4.71; N, 4.22. Measured elemental content (%): C, 81.45; H, 4.72; N, 4.24.

[0131] Synthesis Example 25: Preparation of Compound 568

[0132] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-568, b-568, and c-75 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 568 (35.47 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 798.1986 (theoretical value: 798.1977). Molecular formula C 55 H 30 N₂O₃S, theoretical elemental content (%): C, 82.69; H, 3.79; N, 3.51. Measured elemental content (%): C, 82.72; H, 3.82; N, 3.54.

[0133] Synthesis Example 26: Preparation of Compound 609

[0134] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-609, b-609, and c-609 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 609 (34.85 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 784.2196 (theoretical value: 784.2184). Molecular formula C 55 H 32 N₂O₂S, theoretical elemental content (%): C, 84.16; H, 4.11; N, 3.57. Measured elemental content (%): C, 84.18; H, 4.12; N, 3.58.

[0135] Synthesis Example 27: Preparation of Compound 614

[0136] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-609, b-614, and c-614 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 614 (34.85 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 784.2193 (theoretical value: 784.2184). Molecular formula C 55 H 32N₂O₂S, theoretical elemental content (%): C, 84.16; H, 4.11; N, 3.57. Measured elemental content (%): C, 84.17; H, 4.13; N, 3.61.

[0137] Synthesis Example 28: Preparation of Compound 652

[0138] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-443, b-652, and c-652 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 652 (37.39 g); HPLC purity ≥ 99.95%, mass spectrometry m / z: 841.3183 (theoretical value: 841.3175). Molecular formula C 60 H 35 D5N2OS, theoretical elemental composition (%): C, 85.58; H, 5.39; N, 3.33. Measured elemental composition (%): C, 85.59; H, 5.41; N, 3.36.

[0139] Synthesis Example 29: Preparation of Compound 711

[0140] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-711, b-711, and c-711 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 711 (41.61 g); HPLC purity ≥ 99.98%, mass spectrometry m / z: 936.2252 (theoretical value: 936.2241). Molecular formula C 63 H 32 D4N2OS3, theoretical elemental content (%): C, 80.74; H, 4.30; N, 2.99. Measured elemental content (%): C, 80.75; H, 4.32; N, 3.01.

[0141] Synthesis Example 30: Preparation of Compound 772

[0142] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-395, b-772, and c-308 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 772 (34.19 g); HPLC purity ≥ 99.93%, mass spectrometry m / z: 769.3106 (theoretical value: 769.3093). Molecular formula C 56 H 39N3O, theoretical elemental content (%): C, 87.36; H, 5.11; N, 5.46. Measured elemental content (%): C, 87.39; H, 5.14; N, 5.48.

[0143] Synthesis Example 31: Preparation of Compound 797

[0144] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-797, b-797, and c-797 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 797 (39.79 g); HPLC purity ≥ 99.94%, mass spectrometry m / z: 895.3571 (theoretical value: 895.3563). Molecular formula C 66 H 45 N3O, theoretical elemental content (%): C, 88.46; H, 5.06; N, 4.69. Measured elemental content (%): C, 88.49; H, 5.07; N, 4.72.

[0145] Synthesis Example 32: Preparation of Compound 1009

[0146] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-1009, b-1009, and c-1009 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 1009 (33.83 g); HPLC purity ≥ 99.94%, mass spectrometry m / z: 761.2512 (theoretical value: 761.2501). Molecular formula C 53 H 35 N3OS, theoretical elemental content (%): C, 83.55; H, 4.63; N, 5.51. Measured elemental content (%): C, 83.58; H, 4.64; N, 5.56.

[0147] Synthesis Example 33: Preparation of Compound 1040

[0148] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-1040, b-1040, and c-1040 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 1040 (38.19 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 859.2669 (theoretical value: 859.2657). Molecular formula C 61 H 37N3OS, theoretical elemental content (%): C, 85.19; H, 4.34; N, 4.89. Measured elemental content (%): C, 85.22; H, 4.36; N, 4.91.

[0149] Synthesis Example 34: Preparation of Compound 1080

[0150] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-1080, b-395, and c-1009 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 1080 (36.45 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 820.2977 (theoretical value: 820.2969). Molecular formula C 57 H 24 D 10 N₂O₂S, theoretical elemental content (%): C, 83.39; H, 5.40; N, 3.41. Measured elemental content (%): C, 83.41; H, 5.42; N, 3.42.

[0151] Synthesis Example 35: Preparation of Compound 1193

[0152] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-443, b-1193, and c-1193 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 1193 (33.56 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 755.2126 (theoretical value: 755.2113). Molecular formula C 51 H 25 D5N2OS2, theoretical elemental content (%): C, 81.03; H, 4.67; N, 3.71. Measured elemental content (%): C, 81.05; H, 4.68; N, 3.73.

[0153] Synthesis Example 36: Preparation of Compound 1280

[0154] Following the same synthetic method as compound 23 in Example 4, equimolar amounts of a-1280, b-1280, and c-1280 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 1280 (38.46 g); HPLC purity ≥ 99.96%, mass spectrometry m / z: 865.2249 (theoretical value: 865.2242). Molecular formula C57 H 23 D9N2OS3, theoretical elemental content (%): C, 79.04; H, 4.77; N, 3.23. Measured elemental content (%): C, 79.07; H, 4.78; N, 3.25.

[0155] Synthesis Example 37: Preparation of Compound 1337

[0156] Following the synthesis method of compound 23 in Example 4, equimolar amounts of a-1337, b-1337, and c-1337 were used to replace the original starting materials a-23, b-23, and c-23 to obtain compound 1337 (37.47 g); HPLC purity ≥ 99.97%, mass spectrometry m / z: 843.2897 (theoretical value: 843.2886). Molecular formula C 61 H 37 N3O2, theoretical elemental content (%): C, 86.81; H, 4.42; N, 4.98. Measured elemental content (%): C, 86.84; H, 4.45; N, 4.99.

[0157] Synthesis Example 38: Preparation of Compound 1347

[0158] Compound 414 (11.92 g, 15 mmol), 10% palladium-activated carbon (1.0 g, palladium content 0.1 mmol), and heavy water (100 g) were added to a 1.0 L polytetrafluoroethylene-lined high-pressure reactor and reacted at 240 °C for 12 h, with the pressure in the system rising to 4.0 MPa. After the reaction was completed, the mixture was slowly cooled to room temperature, and ethyl acetate (1.2 L) was added. The aqueous phase (heavy water layer) was extracted and washed three times with 400 mL of ethyl acetate each time. The organic phases were combined, filtered through silica gel, and the filtrate was dried over anhydrous sodium sulfate and filtered again. The solvent was removed by rotary evaporation under reduced pressure to obtain compound 1347 (8.71 g, yield 70%) with an HPLC purity ≥99.96%. Mass spectrometry m / z: 828.4719 (theoretical value: 828.4704). Theoretical elemental content (%) C 57 D 34 N2O3: C, 82.57; H, 8.26; N, 3.38. Measured elemental content (%): C, 82.57; H, 8.26; N, 3.38.

[0159] Device Examples

[0160] In this invention, the ITO glass substrate is ultrasonically cleaned twice with a 5% glass cleaning solution for 20 minutes each time, followed by ultrasonic cleaning twice with deionized water for 10 minutes each time. It is then ultrasonically cleaned sequentially with acetone and isoacetone for 20 minutes each time, and dried at 120°C. All organic materials are sublimated and have a purity of over 99.99%.

[0161] A combined IVL testing system was constructed, consisting of testing software, a computer, a Keithley K2400 digital source meter, and a PhotoResearch PR788 spectrophotometer, to test the driving voltage, luminous efficiency, and CIE color coordinates of organic electroluminescent devices. Lifetime testing was performed using a McScience M6000 OLED lifetime testing system. The testing environment was atmospheric, at room temperature.

[0162] The device was fabricated using a vacuum evaporation system, with continuous evaporation under uninterrupted vacuum conditions. The materials used were housed in separate quartz crucibles containing different evaporation sources, the temperatures of which could be individually controlled. The thermal evaporation rate of organic materials was typically set at 0.1 nm / s, while the evaporation rate of electrode metals ranged from 0.4 to 0.6 nm / s. The prepared glass substrate was then placed in an OLED vacuum coating machine. During the thin film fabrication process, the system vacuum level should be maintained at 5 × 10⁻⁶. -5 Below Pa, organic layers and metal electrodes were deposited by changing the mask. The deposition rate was measured using an Inficon SQM160 quartz crystal film thickness gauge, and the film thickness was measured using a quartz crystal oscillator.

[0163] Example 1: Fabrication of Organic Electroluminescent Device 1

[0164] An ITO / Ag / ITO anode is formed on a glass substrate. A hole injection layer is formed by vacuum evaporating 20 nm of HT-1:HI-1 (mixed at a mass ratio of 97%:3%) on the anode. A hole transport layer is formed by vacuum evaporating 120 nm of compound 23 on the hole injection layer. A light-emitting layer is formed by vacuum evaporating 38 nm of GH-1:GH-2:GD-1 (mixed at a mass ratio of 48%:48%:4%) on the hole transport layer. An electron transport layer is formed by vacuum evaporating 20 nm of ET-1:LiQ (mixed at a mass ratio of 1:1) on the light-emitting layer. A hole blocking layer is formed by vacuum evaporating 5 nm of HB-1 on the electron transport layer. An electron injection layer is formed by vacuum evaporating 1.0 nm of LiF on the hole blocking layer. A cathode is formed by vacuum evaporating 10 nm of Mg and Ag (mass ratio of 1:9) on the electron injection layer. A capping layer is formed by vacuum evaporating 80 nm of compound CP-1 on the cathode.

[0165] Examples 2-35: Fabrication of Organic Electroluminescent Devices 2-35

[0166] The compounds of the present invention listed in Table 1 were used to replace compound 23 in device example 1 as hole transport layer materials. Otherwise, organic electroluminescent devices were prepared using the same preparation method as in device example 1.

[0167] Comparative Examples 1-3: Fabrication of Comparative Organic Electroluminescent Devices 1-3

[0168] By replacing compound 23 in the hole transport layer of Example 1 with R-1, R-2, and R-3, and keeping the other steps the same, comparative organic electroluminescent devices 1 to 3 were obtained.

[0169]

[0170] Table 1: Test results of luminescence characteristics of organic electroluminescent devices 1-35 and comparative examples 1-3

[0171] Note: T95 refers to a current density of 10 mA / cm². 2 Under these conditions, the time it takes for the device's brightness to decay to 95%; As can be seen from Table 1, compared with Comparative Examples 1 to 3, applying the triarylamine heterocyclic compound of the present invention to the hole transport layer can simultaneously improve the luminous efficiency and extend the lifespan of organic electroluminescent devices.

[0172] Example 36: Fabrication of Organic Electroluminescent Device 36

[0173] An ITO / Ag / ITO anode is formed on a glass substrate. A hole injection layer is formed by vacuum evaporating 20 nm of HT-2:HI-1 (mixed at a mass ratio of 97%:3%) on the anode. A hole transport layer is formed by vacuum evaporating 120 nm of HT-2 on the hole injection layer. A light-emitting layer is formed by vacuum evaporating 35 nm of compound 23:RH-1:RD-1 (mixed at a mass ratio of 48%:48%:4%) on the hole transport layer. An electron transport layer is formed by vacuum evaporating 20 nm of ET-2:LiQ (mixed at a mass ratio of 1:1) on the light-emitting layer. A hole blocking layer is formed by vacuum evaporating 5 nm of HB-2 on the electron transport layer. An electron injection layer is formed by vacuum evaporating 1.0 nm of LiF on the hole blocking layer. A cathode is formed by vacuum evaporating 10 nm of Mg and Ag (mass ratio of 1:9) on the electron injection layer. An 80 nm layer of compound CP-2 is formed by vacuum evaporating on the cathode.

[0174] Examples 37-70: Fabrication of Organic Electroluminescent Devices 37-70

[0175] The organic electroluminescent devices were prepared by replacing compound 23 in device example 36 with the compounds of the present invention listed in Table 2 as the main materials, except that the organic electroluminescent devices were prepared by the same preparation method as device example 36.

[0176] Comparative Examples 4-6: Fabrication of Comparative Organic Electroluminescent Devices 4-6

[0177] By replacing compound 23 in the light-emitting layer of Example 36 with R-1, R-2, and R-3, and keeping the other steps the same, comparative organic electroluminescent devices 4-6 were obtained.

[0178]

[0179] Table 2: Test results of luminescent properties of organic electroluminescent devices 36-70 and comparative examples 4-6

[0180] As can be seen from the results in Table 2, compared with Comparative Examples 4 to 6, when the triarylamine heterocyclic organic compound described in this invention is used as the main body of the light-emitting layer of an organic electroluminescent device, the photoelectric performance of the device is significantly improved, and the luminous efficiency and lifetime indicators are outstanding, demonstrating the good applicability of this type of material in the light-emitting layer.

[0181] Example 71: Fabrication of Organic Electroluminescent Device 71

[0182] ITO / Ag / ITO was used as the anode on a glass substrate. A hole injection layer was formed by vacuum evaporating 25 nm of HT-3:HI-2 (mixed at a mass ratio of 97%:3%) on the anode. A hole transport layer was formed by vacuum evaporating 110 nm of HT-3 on the hole injection layer. A light-emitting layer was formed by vacuum evaporating 35 nm of BH-1:BD-1 (mixed at a mass ratio of 97%:3%) on the hole transport layer. An electron transport layer was formed by vacuum evaporating 30 nm of ET-3:LiQ (mixed at a mass ratio of 1:1) on the light-emitting layer. A hole blocking layer was formed by vacuum evaporating 5 nm of HB-3 on the electron transport layer. An electron injection layer was formed by vacuum evaporating 1.0 nm of LiF on the hole blocking layer. A cathode was formed by vacuum evaporating 10 nm of Mg and Ag (mass ratio of 1:9) on the electron injection layer. An 80 nm layer of compound 23 was formed on the cathode.

[0183] Examples 72-105: Fabrication of Organic Electroluminescent Devices 72-105

[0184] The organic electroluminescent devices were prepared by replacing compound 23 in device example 71 with the compounds of the present invention listed in Table 3 as the capping layer, except that the organic electroluminescent devices were prepared by the same preparation method as device example 71.

[0185] Comparative Examples 7-8: Fabrication of Comparative Organic Electroluminescent Devices 7-8

[0186] By replacing compound 23 in the capping layer of Example 71 with R-4 and R-5, and following the same other steps, comparative organic electroluminescent devices 7-8 were obtained.

[0187]

[0188] Table 3: Test results of luminescence characteristics of organic electroluminescent devices 71-105 and comparative examples 7-8

[0189] As can be seen from the results in Table 3, the triarylamine heterocyclic organic compound described in this invention can significantly improve the luminous efficiency and extend the working life of organic electroluminescent devices when used as a capping layer.

[0190] Based on the above performance advantages, triarylamine heterocyclic organic compounds exhibit excellent performance as OLED functional materials, with broad application prospects and significant industrial value.

[0191] It should be noted that the present invention has been specifically described with reference to individual embodiments, but those skilled in the art can make various forms or details of improvements to the present invention without departing from the principles of the present invention, and these improvements also fall within the protection scope of the present invention.

Claims

1. A triarylamine heterocyclic organic compound, characterized in that, The triarylamine heterocyclic organic compound is shown in Formula 1: X1 is selected from O atoms, S atoms, or NR0; The v may be the same or different from CR1, C atom or N atom, and the v at the bonding site is selected from C atom; The ring A is selected from substituted or unsubstituted C6-C30 aromatic rings or substituted or unsubstituted C6-C30 heteroaromatic rings; The Ar1 is selected from the group shown in Formula II: X and Y are selected from O atoms, S atoms, CR2R3 or NR4, whether they are the same or different. The rings B1, B2, and B3 are selected from substituted or unsubstituted aromatic rings of C6 to C30 or heteroaromatic rings of C6 to C30, and at least one of the rings is connected to L1. The R, R1, R2, and R3 are selected from any one of the following: hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C1-C20 heterocycloalkyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring, or substituted or unsubstituted cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring, or two adjacent R1 are connected to each other to form a substituted or unsubstituted ring. R0 and R4 are selected from any one of the following, whether identical or different: hydrogen, deuterium, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring; The Ar is selected from any one of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C1-C20 heterocycloalkyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C6-C30 heteroaryl, substituted or unsubstituted fused cycloyl group of alicyclic and aromatic ring of C3-C20 and C6-C30, and substituted or unsubstituted fused cycloyl group of alicyclic and aromatic ring of C6-C30. L1, L2, and L3 are selected from one of the following: single bond, substituted or unsubstituted C6-C30 arylene, substituted or unsubstituted C2-C30 heteroarylene, substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic rings in a fused cycloalcoholic group, or substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroarylene rings in a fused cycloalcoholic group.

2. The triarylamine heterocyclic organic compound according to claim 1, characterized in that, The " Choose from any of the following structures: The limitation of v is the same as before.

3. The triarylamine heterocyclic organic compound according to claim 1, characterized in that, Formula II is selected from any of the following structures: The limitations of rings B1, B2, B3, R2, R3, and R4 are the same as before.

4. The triarylamine heterocyclic organic compound according to claim 1, characterized in that, Formula II is selected from any of the following structures: The Ra is selected from any one of the following, either identically or differently: hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring. b1 is selected from 0 or 1; b2 is selected from 0, 1 or 2; b3 is selected from 0, 1, 2 or 3; b4 is selected from 0, 1, 2, 3 or 4, either the same or different. The definitions of R2, R3, and R4 are the same as those in claim 1.

5. The triarylamine heterocyclic organic compound according to claim 1, characterized in that, The Ar is selected from any one or a combination of the following structures: The u may be the same or different from CR5, C atom or N atom, and the u at the bonding site is selected from C atom; The ring E is selected from substituted or unsubstituted C3-C15 alicyclic rings; E1, E2, and E4 are selected from O atoms, S atoms, C (R6R7), or N (R8), either the same or different. The E3 is selected from CR9, C atoms, or N atoms; The R5, R6, R7, and R9 are selected from any one of the following, either identically or differently: hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring, or adjacent R5s are interconnected to form substituted or unsubstituted rings; The R8 is selected from any one of the following, either the same as or different from hydrogen, deuterium, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring.

6. The triarylamine heterocyclic organic compound according to claim 1, characterized in that, L1, L2, and L3 may be selected from single bonds, any one of the following structures, or a combination thereof, whether identical or different: The i is selected from CR, whether the i is the same or different. 10 C or N atoms, with the i at the bonding site selected from C atoms; The M is selected from O atoms, S atoms, N(R) atoms, or different atoms. 11 ) or C(R 12 R 13 ); The ring J is selected from substituted or unsubstituted C3 to C15 alicyclic rings; The R 11 The same or different from any one of hydrogen, deuterium, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, and fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring; The R 12 R 13 It may be selected from the same or different groups of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C2-C30 heteroaryl, fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 aromatic ring, or fused cycloalcoholic group of substituted or unsubstituted C3-C20 alicyclic and C6-C30 heteroaryl ring.

7. The triarylamine heterocyclic organic compound according to claim 1, characterized in that, The triarylamine organic compound is derived from any of the following structures: 。 8. An organic electroluminescent device, comprising an anode, a cathode, and an organic layer located between the anode and the cathode or on the side of the cathode facing away from the anode, characterized in that, The organic layer comprises at least one of the triarylamine heterocyclic organic compounds according to any one of claims 1 to 7.

9. An organic electroluminescent device according to claim 8, wherein the organic layer is located between the anode and the cathode, and the organic layer comprises at least one of a hole transport region, a light-emitting layer, and an electron transport region, characterized in that, The hole transport region and at least one of the light-emitting layers comprise at least one of the triarylamine heterocyclic organic compounds according to any one of claims 1 to 7.

10. An organic electroluminescent device according to claim 8, wherein the organic layer is located on the side of the cathode opposite to the anode, and the organic layer comprises a capping layer, characterized in that, The coating layer comprises at least one of the triarylamine heterocyclic organic compounds according to any one of claims 1 to 7.